There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...

Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...

Journal of Nuclear Medicine December 2025, jnumed.125.270792; DOI: https://doi.org/10.2967/jnumed.125.270792 ...

Journal of Nuclear Medicine December 2025, jnumed.125.271365; DOI: https://doi.org/10.2967/jnumed.125.271365 ...

High expression of prostate-specific membrane antigen (PSMA) is not limited to prostate cancer but can be found in other tumor entities, such as hepatocellular carcinoma (HCC), and could possibly be ...

Large language models have become enormously powerful tools for summarizing existing knowledge and generating text, figures, and references for scientific publications. This power can be abused to ...

Journal of Nuclear Medicine October 2025, jnumed.125.271028; DOI: https://doi.org/10.2967/jnumed.125.271028 ...

Journal of Nuclear Medicine October 2025, jnumed.125.270242; DOI: https://doi.org/10.2967/jnumed.125.270242 ...

TO THE EDITOR: In the article written by Veit-Haibach et al. (1), the authors highlight the growing interest in the use of radiopharmaceuticals for both diagnosis and treatment, with a significant ...

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. After the use of liver-directed therapies, it is challenging to differentiate between nonviable tumor and ...

Journal of Nuclear Medicine August 2025, jnumed.125.270317; DOI: https://doi.org/10.2967/jnumed.125.270317 ...